97 related articles for article (PubMed ID: 12541471)
1. [The determination of activated partial thromboplastin time, coagulate time and thrombin time in patients with epistaxis of indeterminate cause].
Huang GW; Zhan LL; Huang JD
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Feb; 14(2):51-2. PubMed ID: 12541471
[TBL] [Abstract][Full Text] [Related]
2. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital.
Chng WJ; Sum C; Kuperan P
Singapore Med J; 2005 Sep; 46(9):450-6. PubMed ID: 16123828
[TBL] [Abstract][Full Text] [Related]
3. Epistaxis: when are coagulation studies justified?
Awan MS; Iqbal M; Imam SZ
Emerg Med J; 2008 Mar; 25(3):156-7. PubMed ID: 18299365
[TBL] [Abstract][Full Text] [Related]
4. [Monitoring heparin therapy by thrombin time and activated partial thromboplastin time--a comparison].
Lang M; Fey MF; Furlan M; Beck EA
Schweiz Med Wochenschr; 1986 Nov; 116(48):1681-4. PubMed ID: 3798064
[TBL] [Abstract][Full Text] [Related]
5. The effect of dabigatran on the activated partial thromboplastin time and thrombin time as determined by the Hemoclot thrombin inhibitor assay in patient plasma samples.
Hapgood G; Butler J; Malan E; Chunilal S; Tran H
Thromb Haemost; 2013 Aug; 110(2):308-15. PubMed ID: 23783268
[TBL] [Abstract][Full Text] [Related]
6. Effect of thrombin receptor expression on microvessel endothelial cells, and survival by coagulation state in oesophageal squamous cell carcinoma.
Shao Y; Xu QQ; Li C; Wu MY; Huang XY
J Clin Pathol; 2012 Aug; 65(8):740-5. PubMed ID: 22685255
[TBL] [Abstract][Full Text] [Related]
7. [Recurrent epistaxis with coagulation disorders in a boy aged 2 years].
Li JZ; Tian X; Liao CS; He XL; Zhu CG
Zhongguo Dang Dai Er Ke Za Zhi; 2022 Jul; 24(7):817-820. PubMed ID: 35894199
[TBL] [Abstract][Full Text] [Related]
8. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent epistaxis in children as an indicator of hemostatic disorders].
García Callejo FJ; Velert Vila MM; Marco Algarra J
An Esp Pediatr; 1998 Nov; 49(5):475-80. PubMed ID: 9949588
[TBL] [Abstract][Full Text] [Related]
10. Significantly different coagulation factor activities underlying the variability of 'normal' activated partial thromboplastin time.
Park KJ; Kwon EH; Ma Y; Park IA; Kim SW; Kim SH; Kim HJ
Blood Coagul Fibrinolysis; 2012 Jan; 23(1):35-8. PubMed ID: 22027757
[TBL] [Abstract][Full Text] [Related]
11. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
[TBL] [Abstract][Full Text] [Related]
12. [Perioperative changes of coagulation functions in the local advanced liver cancer patients receiving liver transplantation].
Wang HY; Zhao QY; Yuan YF
Ai Zheng; 2008 Jul; 27(7):743-7. PubMed ID: 18606069
[TBL] [Abstract][Full Text] [Related]
13. Non-frozen transports of whole blood samples do not cause relevant bias for global coagulation tests in clinical trials evaluating the drug safety.
Totzke U; Kuyas C
Contemp Clin Trials; 2005 Aug; 26(4):488-502. PubMed ID: 16054581
[TBL] [Abstract][Full Text] [Related]
14. Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate.
Douxfils J; Mullier F; Robert S; Chatelain C; Chatelain B; Dogné JM
Thromb Haemost; 2012 May; 107(5):985-97. PubMed ID: 22438031
[TBL] [Abstract][Full Text] [Related]
15. Activated coagulation and activated partial thromboplastin times in assessment and reversal of heparin-induced anticoagulation for cardiopulmonary bypass.
Dauchot PJ; Berzina-Moettus L; Rabinovitch A; Ankeney JL
Anesth Analg; 1983 Aug; 62(8):710-9. PubMed ID: 6869857
[TBL] [Abstract][Full Text] [Related]
16. The influence of laboratory coagulation tests and clotting factor levels on Rotation Thromboelastometry (ROTEM(R)) during major surgery with hemorrhage.
Theusinger OM; Schröder CM; Eismon J; Emmert MY; Seifert B; Spahn DR; Baulig W
Anesth Analg; 2013 Aug; 117(2):314-21. PubMed ID: 23780419
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies in pediatric patients with prolonged activated partial thromboplastin time during infection.
Frauenknecht K; Lackner K; von Landenberg P
Immunobiology; 2005; 210(10):799-805. PubMed ID: 16325500
[TBL] [Abstract][Full Text] [Related]
18. The monitoring of heparin administration by screening tests in experimental dogs.
Mischke R; Jacobs C
Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
[TBL] [Abstract][Full Text] [Related]
19. [Activated partial thromboplastin time prolongation in paediatrics. Retrospective monocentric study at the Nice University Hospital].
Benadiba J; Monpoux F; Appert-Flory A; Fischer F; Sirvent N
Pathol Biol (Paris); 2011 Dec; 59(6):314-8. PubMed ID: 20822861
[TBL] [Abstract][Full Text] [Related]
20. Influence of temperature and storage duration on measurement of activated partial thromboplastin time, D-dimers, fibrinogen, prothrombin time and thrombin time, in citrate-anticoagulated whole blood specimens.
Zhao Y; Lv G
Int J Lab Hematol; 2013 Oct; 35(5):566-70. PubMed ID: 23718185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
